Future studies with appropriate controls, serial inflammatory and coagulation biomarkers (e.g., IL-6, CRP, D-dimer), and vessel-wall imaging could better delineate whether a subset of SAH during COVID-19 reflects causal biology versus coincidence. This evidence concerns the gene CRP and COVID-19.